Global Antisense & RNAi Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Antisense & RNAi Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Antisense & RNAi Therapeutics market size was valued at USD 986.3 million in 2023 and is forecast to a readjusted size of USD 1303.9 million by 2030 with a CAGR of 4.1% during review period.

Antisense therapy is a form of treatment for genetic disorders or infections. When the genetic sequence of a particular gene is known to be causative of a particular disease, it is possible to synthesize a strand of nucleic acid (DNA, RNA or a chemical analogue) that will bind to the messenger RNA (mRNA) produced by that gene and inactivate it, effectively turning that gene "off".

North America is a key market, with U.S. reflecting a number of RNAi therapeutics currently in developmental pipelines. A number of biotechnology companies have made considerably high investments for RNAi therapeutic development. Big pharmaceutical developers have entered into collaboration agreements or licensing deals with a number of smaller firms in an attempt to capitalize on the expected revenue growth of this market.

The Global Info Research report includes an overview of the development of the Antisense & RNAi Therapeutics industry chain, the market status of Oncology (RNA Interference, SiRNA), Cardiovascular (RNA Interference, SiRNA), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antisense & RNAi Therapeutics.

Regionally, the report analyzes the Antisense & RNAi Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antisense & RNAi Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Antisense & RNAi Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antisense & RNAi Therapeutics industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., RNA Interference, SiRNA).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antisense & RNAi Therapeutics market.

Regional Analysis: The report involves examining the Antisense & RNAi Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antisense & RNAi Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Antisense & RNAi Therapeutics:

Company Analysis: Report covers individual Antisense & RNAi Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antisense & RNAi Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiovascular).

Technology Analysis: Report covers specific technologies relevant to Antisense & RNAi Therapeutics. It assesses the current state, advancements, and potential future developments in Antisense & RNAi Therapeutics areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antisense & RNAi Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Antisense & RNAi Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
RNA Interference
SiRNA
MiRNA
Antisense RNA

Market segment by Application
Oncology
Cardiovascular
Renal
Neurodegenerative
Respiratory
Genetic
Infectious Diseases

Market segment by players, this report covers
Glaxo Smith Kline
Sanofi Aventis / Genzyme
Isis Pharmaceuticals/ Ionis Pharmaceuticals
Arbutus Biopharma Ltd.
Silence Therapeutics
Bio-Path Holdings Inc.
Calando Pharmaceuticals
ICo Therapeutics
Quark Pharmaceuticals
Rexhan Pharmaceuticals
Biomarin/Prosensa
Regulus Therapeutics
Rxi Pharmaceuticals
Silenseed
Dicerna Pharmaceuticals
Sirnaomics Inc.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Antisense & RNAi Therapeutics product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Antisense & RNAi Therapeutics, with revenue, gross margin and global market share of Antisense & RNAi Therapeutics from 2019 to 2024.

Chapter 3, the Antisense & RNAi Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Antisense & RNAi Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Antisense & RNAi Therapeutics.

Chapter 13, to describe Antisense & RNAi Therapeutics research findings and conclusion.